Search Results

East Region Formulary ERFC Minutes 27 March 2024 Page 1 of 11 East Region Formulary Committee Minutes Date: 27 March 2024 Time: 2.00pm – 4.00pm Location: MS Teams Present: Carla Capaldi ...

SMC2592 : For the treatment of active moderate to severe hidradenitis suppurativa (HS) (acne inversa) in adults with an inadequate response to conventional systemic HS therapy. SMC restriction: for u...

1054/15 : Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

1159/16 : Treatment of active ankylosing spondylitis (AS) in adults who have responded inadequately to conventional therapy.

TA445 (SMC 1167/16) : Alone or in combination with methotrexate, for the treatment of active psoriatic arthritis in adult patients when the response to previous disease-modifying anti-rheumatic drug (...

SMC2308 : For the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging ...